You are here: Industry Insights > array biopharma

News List

Pfizer to buy Array Biopharma for $10.64 bn in cash expresspharma
June 21, 2019
Pfizer will buy Array Biopharma for $10.64 billion in cash, a deal it hopes will help make it a leader in colon cancer and build up its pipeline of oncology drugs.
Pfizer to acquire US company Array BioPharma for $11.4bn pharmaceutical-technology
June 19, 2019
Pfizer has signed a definitive merger agreement to acquire US-based, commercial-stage biopharmaceutical company Array BioPharma.
Pfizer to acquire Array BioPharma in a $11.4B deal biospectrumasia
June 18, 2019
Proposed acquisition strengthens Pfizer’s innovative biopharmaceutical business and is expected to accelerate its growth trajectory particularly in the long term
Array BioPharma Announces BRAFTOVI + MEKTOVI + Cetuximab Meet Primary Endpoints americanpharmaceuticalreview
May 22, 2019
Array BioPharma announced positive results from the interim analysis of the Phase 3 BEACON CRC trial evaluating the combination of BRAFTOVI® (encorafenib), a BRAF inhibitor, MEKTOVI® (binimetinib) ...
Array BioPharma collaborates with Pfizer biospectrumasia
November 19, 2018
Novel combinations of binimetinib (MEK), avelumab (PD-L1), and talazoparib (PARP inhibitor) to be studied across tumor types
Array BioPharma Touts Phase III Results for Melanoma Therapy biospace
March 23, 2018
Shares of Array BioPharma, Inc. are climbing this morning after the company released detailed results for its late-stage combination treatment for metastatic melanoma.
Array Biopharma Spun Off Heart Drug R&D Into New Subsidiary Yarra Therapeutics biospace
December 28, 2017
Array BioPharma has spun out some of its intellectual property and equipment into a new company, Yarra Therapeutics. Note that Yarra is Array spelled backwards.
Array BioPharma (ARRY) Price Target Increased to $13.00 by Analysts at Jefferies Group americanbankingnews
December 26, 2017
Array BioPharma (NASDAQ:ARRY) had its price objective raised by equities research analysts at Jefferies Group to $13.00 in a note issued to investors on Friday